Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice
Lin Wang(SickKids Foundation), Spencer A. Freeman(University of Toronto), Meera Mehta(University of Toronto), Sarit Cohen‐Kedar(Tel Aviv University), Kaiyue Peng(Children's Hospital of Fudan University), Yuesheng Wang(Shanghai Jiao Tong University), Liren Wang(SickKids Foundation), Neil Warner(SickKids Foundation), Melania Capitani(John Radcliffe Hospital), Conghui Guo(University of Toronto), Samuel J. Bullers(Nuffield Orthopaedic Centre), Daniel Mayr(Austrian Academy of Sciences), Ana‐Iris Schiefer(University of Vienna), Iris Dotan(Tel Aviv University), Chien-Yi Lu(University of Toronto), Klaus Warnatz(University of Freiburg), Sophie Hambleton(Newcastle upon Tyne Hospitals NHS Foundation Trust), Gergely Kriván(National Center for Epidemiology), Michael G. Surette(McMaster University), Daniel Kotlarz(LMU Klinikum), Anís N. Gammage(Nuffield Orthopaedic Centre), Siew C. Ng(Chinese University of Hong Kong), Dilan Dissanayake(Hospital for Sick Children), Mathieu Lemaire(University of Toronto), Li Qi(University of Toronto), Helen Griffin(NIHR Newcastle Biomedical Research Centre), Rico Chandra Ardy(Austrian Academy of Sciences), Iram Siddiqui(Hospital for Sick Children), Daniel J. Mulder(SickKids Foundation), Zhiyang Zeng(Xian Central Hospital), Dominik Aschenbrenner(John Radcliffe Hospital), Jie Pan(Ministry of Education of the People's Republic of China), Karin R. Engelhardt(Newcastle University), Bodo Grimbacher(University Medical Center Freiburg), Vera Goda(National Center for Epidemiology), Suzanne Elcombe(Royal Victoria Infirmary), Tao Zuo(Sun Yat-sen University), Ronald M. Laxer(Hospital for Sick Children), Michele Proietti(University of Freiburg), Xiya Cao(East China Normal University), Robert Rottapel(Ontario Institute for Cancer Research), Xiaobing Wang(Shanghai Changzheng Hospital), Xiaoqin Li(Shanghai Ocean University), Zhiheng Huang(Children's Hospital of Fudan University), Jiawei Lu(Chinese University of Hong Kong), Hélène Decaluwe(Centre Hospitalier Universitaire Sainte-Justine), Shuchao Li, Walter H.A. Kahr(University of Toronto)
Cited by 106
Related Papers
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
|New England Journal of Medicine|2014|889